Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 2
1992 5
1993 2
1994 3
1995 8
1996 8
1997 5
1998 13
1999 12
2000 9
2001 22
2002 12
2003 18
2004 21
2005 23
2006 8
2007 12
2008 24
2009 35
2010 41
2011 37
2012 36
2013 30
2014 21
2015 19
2016 22
2017 15
2018 20
2019 12
2020 5
2021 8
2022 8
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

492 results

Results by year

Filters applied: . Clear all
Page 1
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.
Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A. Meehan CJ, et al. Among authors: van soolingen d. Nat Rev Microbiol. 2019 Sep;17(9):533-545. doi: 10.1038/s41579-019-0214-5. Nat Rev Microbiol. 2019. PMID: 31209399 Review.
Differential rates of Mycobacterium tuberculosis transmission associate with host-pathogen sympatry.
Gröschel MI, Pérez-Llanos FJ, Diel R, Vargas R Jr, Escuyer V, Musser K, Trieu L, Meissner JS, Knorr J, Klinkenberg D, Kouw P, Homolka S, Samek W, Mathema B, van Soolingen D, Niemann S, Ahuja SD, Farhat MR. Gröschel MI, et al. Among authors: van soolingen d. Nat Microbiol. 2024 Aug;9(8):2113-2127. doi: 10.1038/s41564-024-01758-y. Epub 2024 Aug 1. Nat Microbiol. 2024. PMID: 39090390
[Nontuberculous mycobacteria: clinically relevant].
van Ingen J, Hoefsloot W, de Lange WC, Magis-Escurra C, Dekhuijzen PN, Boeree MJ, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Ned Tijdschr Geneeskd. 2010;154:A1178. Ned Tijdschr Geneeskd. 2010. PMID: 20482903 Review. Dutch.
Nontuberculous mycobacteria, zambia.
Buijtels PC, van-der-Sande MA, de-Graaff CS, Parkinson S, Verbrugh HA, Petit PL, van-Soolingen D. Buijtels PC, et al. Among authors: van soolingen d. Emerg Infect Dis. 2009 Feb;15(2):242-9. doi: 10.3201/eid1502.080006. Emerg Infect Dis. 2009. PMID: 19193268 Free PMC article.
Clinical standards for the dosing and management of TB drugs.
Alffenaar JWC, Stocker SL, Forsman LD, Garcia-Prats A, Heysell SK, Aarnoutse RE, Akkerman OW, Aleksa A, van Altena R, de Oñata WA, Bhavani PK, Van't Boveneind-Vrubleuskaya N, Carvalho ACC, Centis R, Chakaya JM, Cirillo DM, Cho JG, D Ambrosio L, Dalcolmo MP, Denti P, Dheda K, Fox GJ, Hesseling AC, Kim HY, Köser CU, Marais BJ, Margineanu I, Märtson AG, Torrico MM, Nataprawira HM, Ong CWM, Otto-Knapp R, Peloquin CA, Silva DR, Ruslami R, Santoso P, Savic RM, Singla R, Svensson EM, Skrahina A, van Soolingen D, Srivastava S, Tadolini M, Tiberi S, Thomas TA, Udwadia ZF, Vu DH, Zhang W, Mpagama SG, Schön T, Migliori GB. Alffenaar JWC, et al. Among authors: van soolingen d. Int J Tuberc Lung Dis. 2022 Jun 1;26(6):483-499. doi: 10.5588/ijtld.22.0188. Int J Tuberc Lung Dis. 2022. PMID: 35650702 Free PMC article.
XDR tuberculosis.
van Ingen J, de Lange WC, Boeree MJ, Iseman MD, Daley CL, Heifets LB, Böttger EC, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Lancet Infect Dis. 2011 Aug;11(8):585. doi: 10.1016/S1473-3099(11)70200-6. Lancet Infect Dis. 2011. PMID: 21798459 No abstract available.
Nontuberculous mycobacteria in respiratory tract infections, eastern Asia.
Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, van Soolingen D. Simons S, et al. Among authors: van soolingen d. Emerg Infect Dis. 2011 Mar;17(3):343-9. doi: 10.3201/eid1703.100604. Emerg Infect Dis. 2011. PMID: 21392422 Free PMC article. Review.
Emerging drugs and alternative possibilities in the treatment of tuberculosis.
Hofman S, Segers MM, Ghimire S, Bolhuis MS, Sturkenboom MG, Van Soolingen D, Alffenaar JW. Hofman S, et al. Among authors: van soolingen d. Expert Opin Emerg Drugs. 2016;21(1):103-16. doi: 10.1517/14728214.2016.1151000. Epub 2016 Feb 20. Expert Opin Emerg Drugs. 2016. PMID: 26848966 Review.
492 results